AngioDynamics, Inc. v. C.R. Bard, Inc. et al

Filing 458

ORDER: as to evidentiary rulings regarding witnesses Aldrich, Chartrand, Kertesz, and Sands. Signed by Chief Judge Brenda K. Sannes on 9/25/2022. (nmk)

Case No. 1:17-cv-598 (BKS)(CFH)
Date:_________ Presiding Judge: Honorable Brenda K. Sannes

United States District Court
For the Northern District of New York

AngioDynamics' Responses to Bard's Affirmative Deposition Designations (ECF #417)

Name of Deponent
Aldrich, Thomas
Aldrich, Thomas
Aldrich, Thomas
Aldrich, Thomas
Aldrich, Thomas
Aldrich, Thomas
Aldrich, Thomas

Aldrich, Thomas

Aldrich, Thomas

Aldrich, Thomas

Aldrich, Thomas

Aldrich, Thomas

Date of Testimony
December 5, 2019
December 5, 2019
December 5, 2019
December 5, 2019
December 5, 2019
December 5, 2019
December 5, 2019

December 5, 2019

December 5, 2019

December 5, 2019

December 5, 2019

December 5, 2019

Affirmative Page Affirmative Line
From
From
7
9
12
25
26
51
65

66

67

69

70

71

8
2
12
6
11
25
6

24

15

14

19

8

Affirmative
Page To

Affirmative
Line To

7
9
12
25
26
52
66

67

67

70

71

71

9
10
14
10
15
14
5

11

20

17

6

20

AngioDynamics' Objections to Affirmative
Designations

AngioDynamics'
Counter-Designations

Court’s Ruling

403/Cumulative (Morpheus recall)
403/Cumulative (Morpheus recall)
403/Cumulative (Morpheus recall)
403/Cumulative (Morpheus recall)
403/Cumulative & Prejudicial - the testimony
relates to loss of business not specific to PICCs
and without reference to type of PICC and
relevance is substantially outweighed by
prejudice and juror confusion; 76:11-77:3 below
is specific to BioFlo PICC
403/Cumulative & Prejudicial - the testimony
relates to loss of business not specific to PICCs
and without reference to type of PICC and
relevance is substantially outweighed by
prejudice and juror confusion; 76:11-77:3 below
is specific to BioFlo PICC
403/Cumulative & Prejudicial - the testimony
relates to loss of business not specific to PICCs
and without reference to type of PICC and
relevance is substantially outweighed by
prejudice and juror confusion; 76:11-77:3 below
is specific to BioFlo PICC
403/Cumulative & Prejudicial - the testimony
relates to loss of business not specific to PICCs
and without reference to type of PICC and
relevance is substantially outweighed by
prejudice and juror confusion; 76:11-77:3 below
is specific to BioFlo PICC
403/Cumulative & Prejudicial - the testimony
relates to loss of business not specific to PICCs
and without reference to type of PICC and
relevance is substantially outweighed by
prejudice and juror confusion; 76:11-77:3 below
is specific to BioFlo PICC

83:11-84:2
83:11-84:2
51:20-24; 83:11-84:2
83:11-84:2

Sustained
Overruled
Sustained
Sustained

67:12-14; 83:11-84:1

Overruled

83:11-84:2

Overruled

83:11-84:1

Sustained as to 70:1670:17 and otherwise
overruled

83:11-84:2

Sustained

83:11-84:2

Sustained

Case No. 1:17-cv-598 (BKS)(CFH)
Date:_________ Presiding Judge: Honorable Brenda K. Sannes

Name of Deponent

Date of Testimony

United States District Court
For the Northern District of New York

Affirmative Page Affirmative Line
From
From

Affirmative
Page To

Affirmative
Line To

AngioDynamics' Objections to Affirmative
Designations

Aldrich, Thomas
Aldrich, Thomas
Aldrich, Thomas
Aldrich, Thomas
Aldrich, Thomas
Aldrich, Thomas
Aldrich, Thomas
Aldrich, Thomas
Aldrich, Thomas
Aldrich, Thomas
Aldrich, Thomas
Aldrich, Thomas
Aldrich, Thomas

December 5, 2019
December 5, 2019
December 5, 2019
December 5, 2019
December 5, 2019
December 5, 2019
December 5, 2019
December 5, 2019
December 5, 2019
December 5, 2019
December 5, 2019
December 5, 2019
December 5, 2019

76
76
84
85
86
87
90
96
101
102
105
107
108

11
24
19
8
22
17
9
17
11
14
2
15
8

76
77
84
85
87
88
91
97
101
102
106
108
109

23
3
22
21
13
16
23
20
20
25
12
3
4

Aldrich, Thomas

December 5, 2019

109

24

110

20

Aldrich, Thomas

December 5, 2019

111

24

112

4

Aldrich, Thomas

December 5, 2019

114

4

115

10

Aldrich, Thomas

December 5, 2019

117

22

118

10

Aldrich, Thomas
Aldrich, Thomas
Aldrich, Thomas
Aldrich, Thomas
Aldrich, Thomas
Aldrich, Thomas
Aldrich, Thomas
Aldrich, Thomas
Aldrich, Thomas

December 5, 2019
December 5, 2019
December 5, 2019
December 5, 2019
December 5, 2019
December 5, 2019
December 5, 2019
December 5, 2019
December 5, 2019

118
120
122
123
131
132
135
139
140

12
3
20
5
13
19
19
6
3

119
122
122
123
132
133
136
139
140

16
12
24
8
15
5
17
13
8

AngioDynamics'
Counter-Designations

Court’s Ruling

83:11-84:2
83:11-84:2;88:17-89:13
83:11-84:1; 88:17-89:13
83:11-84:1; 88:17-89:13
83:11-84:2:88:17-89:13
Document discussed is not on Bard's Exhibit
Document discussed is not on Bard's Exhibit
Document discussed is not on Bard's Exhibit
Document discussed is not on Bard's Exhibit
Document discussed is not on Bard's Exhibit
Document discussed is not on Bard's Exhibit
403/Cumulative (Morpheus recall); Morpheus is
not part of damages and the amount of lost
Morpheus revenue is irrelevant and confusing
403/Cumulative (Morpheus recall); Morpheus is
not part of damages and the amount of lost
Morpheus revenue is irrelevant and confusing
403/Cumulative (Morpheus recall); Morpheus is
not part of damages and the amount of lost
Morpheus revenue is irrelevant and confusing
403/Cumulative (Morpheus recall); Morpheus is
not part of damages and the amount of lost
Morpheus revenue is irrelevant and confusing
403/Cumulative (Morpheus recall); Morpheus is
not part of damages and the amount of lost
Morpheus revenue is irrelevant and confusing

106:18-107:14

Sustained
Overruled (exhibit D-85)
Overruled
Overruled
Overruled
Overruled
Overruled

112:5-10

Overruled

115:24-116:13; 116:1517; 116:19-20

Overruled
Overruled
Overruled

74:5-19; 123:22-124:17

Case No. 1:17-cv-598 (BKS)(CFH)
Date:_________ Presiding Judge: Honorable Brenda K. Sannes

Name of Deponent

Aldrich, Thomas
Aldrich, Thomas
Aldrich, Thomas

Date of Testimony

December 5, 2019
December 5, 2019
December 5, 2019

United States District Court
For the Northern District of New York

Affirmative Page Affirmative Line
From
From

140
143
143

17
2
6

Affirmative
Page To

141
143
143

Affirmative
Line To

AngioDynamics' Objections to Affirmative
AngioDynamics'
Designations
Counter-Designations
141:3-10: designation is misleading because it
refers to "all the hospitals" in the email and not
all the hospitals are included or identified in the 141:11-19
prior designations and witness also says he does
10 not know whether any are lost customers
Obj. to Ex. D-075 see ECF #411; hearsay (no
communication or representation of
communication from hospital), 403/cumulative reference to lack of navigation is minor to the
Obj. to D-075 as above
Obj. to D-075 as above
149:1-5
Obj. to D-075 as above
Obj. to D-075 as above
161:16-162:3; 163;22164:4; 164:15-21
165:6-8; 165:10-13

December 5, 2019
December 5, 2019
December 5, 2019
December 5, 2019
December 5, 2019

146
147
149
149
149

20
12
7
18
23

147
148
149
149
150

5
20
13
20
7

Aldrich, Thomas
Aldrich, Thomas
Aldrich, Thomas
Aldrich, Thomas
Aldrich, Thomas

December 5, 2019
December 5, 2019
December 5, 2019
December 5, 2019
December 5, 2019

162
165
165
166
186

23
16
20
4
24

163
165
166
166
187

6
18
2
6
7

Aldrich, Thomas
Aldrich, Thomas
Aldrich, Thomas
Aldrich, Thomas
Aldrich, Thomas
Aldrich, Thomas
Aldrich, Thomas
Aldrich, Thomas
Aldrich, Thomas

December 5, 2019
December 5, 2019
December 5, 2019
December 5, 2019
December 5, 2019
December 5, 2019
December 5, 2019
December 5, 2019
December 5, 2019

188
189
194
224
229
233
233
237
238

4
3
12
6
8
2
14
25
9

188
189
195
224
229
233
233
238
239

13 means.
9
23
15
17
12
14
7
16

Designation is unspecific as what "at the time"

December 5, 2019
December 5, 2019
December 5, 2019
December 5, 2019
December 5, 2019

240
242
243
280
281

9
9
7
23
6

241
242
244
281
282

Overruled

4
17

Aldrich, Thomas
Aldrich, Thomas
Aldrich, Thomas
Aldrich, Thomas
Aldrich, Thomas

Aldrich, Thomas
Aldrich, Thomas
Aldrich, Thomas
Aldrich, Thomas
Aldrich, Thomas

Court’s Ruling

Overruled
Overruled
Overruled
Overruled

Sustained
202:1-203:17
235:25-236:23
235:25-236:23
237:20-24

241:9-18 403; see Obj. to Ex. D-036 at ECF
#411; hearsay; 403

18
22 See Obj. to D-036 above
8 See Obj. to D-036 above
4
7

Overruled (relevant parts
not hearsay)

247:10-22

Sustained as to 240:9 241:10; Overruled as to
the rest
Overruled
Overruled

Case No. 1:17-cv-598 (BKS)(CFH)
Date:_________ Presiding Judge: Honorable Brenda K. Sannes

Name of Deponent

Date of Testimony

United States District Court
For the Northern District of New York

Affirmative Page Affirmative Line
From
From

Affirmative
Page To

Affirmative
Line To

AngioDynamics' Objections to Affirmative
Designations
Hearsay; see Obj. to Ex. D-175 at ECF #411;
23 hearsay 403
17 See Obj. D-175 above
Hearsay, 403; see Obj. to D-199 at ECF #411;
14 hearsay, 403

Aldrich, Thomas
Aldrich, Thomas

December 5, 2019
December 5, 2019

288
291

5
25

288
292

Aldrich, Thomas
Aldrich, Thomas
Aldrich, Thomas

December 5, 2019
December 5, 2019
December 5, 2019

340
348
367

10
15
25

342
349
369

Aldrich, Thomas
Aldrich, Thomas
Aldrich, Thomas
Aldrich, Thomas
Aldrich, Thomas

December 5, 2019
December 5, 2019
December 5, 2019
December 5, 2019
December 5, 2019

369
369
370
371
371

8
22
12
3
5

369
370
370
371
372

8
10
24
3
2

Aldrich, Thomas
Aldrich, Thomas

December 5, 2019
December 5, 2019

378
379

25
11

379
379

9 designation; lacks any predicate
21

Aldrich, Thomas

December 5, 2019

389

22

390

22 ECF #411

AngioDynamics'
Counter-Designations
289:10-290:3

4
5

Sustained (first line of
question only)

Designation is first line of an answer only

Overruled (complete with
next designation)

Hearsay; 403/cumulative; see Obj. to D-072 at

December 5, 2019

391

14

393

Aldrich, Thomas
Aldrich, Thomas
Aldrich, Thomas
Aldrich, Thomas
Aldrich, Thomas
Chartrand, Brad
Chartrand, Brad
Chartrand, Brad
Chartrand, Brad
Chartrand, Brad

December 5, 2019
December 5, 2019
December 5, 2019
December 5, 2019
February 27, 2020
February 27, 2020
February 27, 2020
February 27, 2020
February 27, 2020
February 27, 2020

393
395
397
399
407
6
12
21
22
30

7
13
23
4
18
5
9
21
11
4

393
396
398
399
408
6
12
21
22
31

Chartrand, Brad

February 27, 2020

55

11

55

Chartrand, Brad

February 27, 2020

56

13

56

Sustained (hearsay in D175)
Sustained
Overruled

378:25-379:5 appears to be incomplete

Aldrich, Thomas

Court’s Ruling

Hearsay; 403/cumulative; see Obj. to D-072 at
5 ECF #411
Hearsay; 403/cumulative; see Obj. to D-072 at
21 ECF #411; hearsay, 403
4
3
24
5
7
15 Incomplete designation
23
15
15

Hearsay; 403/cumulative see Obj. to D-022 at
ECF #411 re TLS- witness says statements in
23 document are not from a customer 58:24-59:20
Hearsay; 403/cumulative see Obj. to D-022 at
ECF #411 re TLS- witness says statements in
22 document are not from a customer 58:24-59:20

Overruled (inquiry)
Overruled
416:16-417:7

Overruled

408:6-18
12:16-20

Overruled

22:18-23:2
Overruled (relevant
portion inquiry)
Overruled

Case No. 1:17-cv-598 (BKS)(CFH)
Date:_________ Presiding Judge: Honorable Brenda K. Sannes

Name of Deponent

Date of Testimony

United States District Court
For the Northern District of New York

Affirmative Page Affirmative Line
From
From

Affirmative
Page To

Affirmative
Line To

Chartrand, Brad

February 27, 2020

57

4

58

4

Chartrand, Brad
Chartrand, Brad
Chartrand, Brad
Chartrand, Brad
Chartrand, Brad
Chartrand, Brad
Chartrand, Brad
Chartrand, Brad
Chartrand, Brad
Chartrand, Brad
Chartrand, Brad
Chartrand, Brad
Chartrand, Brad
Chartrand, Brad
Chartrand, Brad
Chartrand, Brad
Chartrand, Brad
Chartrand, Brad
Chartrand, Brad
Chartrand, Brad
Chartrand, Brad
Chartrand, Brad
Chartrand, Brad
Chartrand, Brad
Chartrand, Brad
Chartrand, Brad
Chartrand, Brad
Chartrand, Brad
Chartrand, Brad

February 27, 2020
February 27, 2020
February 27, 2020
February 27, 2020
February 27, 2020
February 27, 2020
February 27, 2020
February 27, 2020
February 27, 2020
February 27, 2020
February 27, 2020
February 27, 2020
February 27, 2020
February 27, 2020
February 27, 2020
February 27, 2020
February 27, 2020
February 27, 2020
February 27, 2020
February 27, 2020
February 27, 2020
February 27, 2020
February 27, 2020
February 27, 2020
February 27, 2020
February 27, 2020
February 27, 2020
February 27, 2020
February 27, 2020

60
62
62
66
66
67
67
70
70
72
72
72
78
78
79
79
80
80
80
81
81
95
100
100
100
101
101
101
115

11
11
16
13
21
9
13
2
6
19
23
25
12
17
18
21
8
13
22
13
17
21
3
20
24
9
13
19
3

60
62
62
66
67
67
67
70
70
72
72
73
78
78
79
80
80
80
81
81
82
96
100
100
101
101
101
101
116

18
14
19
19
7
11
13
4
6
21
23
16
15
18
19
6
11
20
2
15
4
24
10
22
7
11
17
20
2

Chartrand, Brad

February 27, 2020

116

9

116

Chartrand, Brad

February 27, 2020

116

25

117

AngioDynamics' Objections to Affirmative
AngioDynamics'
Designations
Counter-Designations
Obj. to D-022 Hearsay; 403/cumulative re TLSwitness says statements in document are not
from a customer 58:24-59:20
Obj. to D-022 Hearsay; 403/cumulative re TLSwitness says statements in document are not
from a customer 58:24-59:20
Vague, compound, speculative
Vague, compound, speculative

Court’s Ruling
Overruled
Overruled
Sustained
Sustained

67:4-7 Compound, speculative, assumes facts
67:9 Compound, speculative, assumes facts

Overruled
Overruled

Vague, compound, incomplete hypothetical
Vague, compound, incomplete hypothetical

Sustained
Sustained
73:17-74:1

Vague, speculative
Vague, speculative
403/cumulative see Obj. to D-049 at ECF # 411
403/cumulative see Obj. to D-049 above
403/cumulative see Obj. to D-049 above
403/cumulative see Obj. to D-049 above
403/cumulative see Obj. to D-049 above
403/cumulative see Obj. to D-049 above
403/cumulative see Obj. to D-049 above
101:21-102:9
403; D-058 - see Obj. to D-058 at ECF # 411
403, Obj. to D-058 above; 116:21-23 no
23 foundation, speculation, compound
Obj. to D-058 above; no foundation,
13 speculation, compound

Overruled
Overruled
Overruled
Overruled
Overruled
Overruled
Overruled
Overruled
Overruled
Sustained
Sustained
Sustained

Case No. 1:17-cv-598 (BKS)(CFH)
Date:_________ Presiding Judge: Honorable Brenda K. Sannes

Name of Deponent

Date of Testimony

United States District Court
For the Northern District of New York

Affirmative Page Affirmative Line
From
From

Affirmative
Page To

Affirmative
Line To

AngioDynamics' Objections to Affirmative
Designations
Obj. to D-058 above; no foundation,
17 speculation, compound
Obj. to D-058 above; no foundation,
20 speculation, compound
Obj. to D-058 above; no foundation,
3 speculation, compound

Chartrand, Brad

February 27, 2020

117

15

117

Chartrand, Brad

February 27, 2020

117

19

117

Chartrand, Brad
Chartrand, Brad
Chartrand, Brad

February 27, 2020
February 27, 2020
February 27, 2020

117
125
126

22
14
11

118
126
128

Chartrand, Brad

February 27, 2020

131

22

131

23 not know

Chartrand, Brad

February 27, 2020

131

25

132

4 not know

Chartrand, Brad

February 27, 2020

132

6

132

11 with a rumor and reference to "hearsay"

Chartrand, Brad

February 27, 2020

132

13

133

4 with a rumor and reference to "hearsay"

Chartrand, Brad
Chartrand, Brad
Chartrand, Brad

February 27, 2020
February 27, 2020
February 27, 2020

133
133
133

6
18
23

133
133
134

16 responded he did know if his understanding was
21 Vague, assumes facts
3 Vague, assumes facts, non-responsive

Chartrand, Brad
Chartrand, Brad
Chartrand, Brad
Chartrand, Brad
Chartrand, Brad
Chartrand, Brad
Chartrand, Brad

February 27, 2020
February 27, 2020
February 27, 2020
February 27, 2020
February 27, 2020
February 27, 2020
February 27, 2020

134
145
145
164
176
178
178

18
16
20
6
9
14
18

135
145
145
164
176
178
179

11
18
21
22
13
16
19

3
17

AngioDynamics'
Counter-Designations

Sustained
Sustained
118:4-15

Sustained

Foundation, speculation, witness responded did

Sustained

Foundation, speculation, witness responded

Sustained

Foundation, speculation, witness responded

Sustained

133:6-7 Foundation, speculation, witness

Answer is a question; examiner rephrases at
179:24-180:2

February 27, 2020

179

21

179

21

Chartrand, Brad

February 27, 2020

180

17

180

19 foundation

Chartrand, Brad

February 27, 2020

180

21

181

Assumes facts that Angio approached Teleflex,
Assumes facts that Angio approached Teleflex,

185

15

185

Sustained as to 133:6-7
Overruled
Overruled
135:12-14; 135:16-21;
135:23-136:1

Chartrand, Brad

February 27, 2020

Sustained

130:10-14
Foundation, speculation, witness responded did

Chartrand, Brad

Court’s Ruling

9 foundation not cured by witness

Asks for lay opinion, foundation, designations
incomplete to describe "the deal you were
17 describing"

179:24-180:4-180:16

Sustained subject to cure
by including rephrased
question and answer
Overruled
Overruled
Overruled

Case No. 1:17-cv-598 (BKS)(CFH)
Date:_________ Presiding Judge: Honorable Brenda K. Sannes

Name of Deponent

Date of Testimony

United States District Court
For the Northern District of New York

Affirmative Page Affirmative Line
From
From

Affirmative
Page To

Affirmative
Line To

Chartrand, Brad

February 27, 2020

185

20

185

21

Chartrand, Brad

February 27, 2020

213

22

214

2

Chartrand, Brad

February 27, 2020

214

6

216

13

Chartrand, Brad

February 27, 2020

216

15

217

9

Chartrand, Brad

February 27, 2020

217

11

217

14

Chartrand, Brad

February 27, 2020

217

17

217

22

Chartrand, Brad

February 27, 2020

217

25

218

2

Kertesz, Maria

January 16, 2020

7

11

19

10

Kertesz, Maria
Kertesz, Maria
Kertesz, Maria
Kertesz, Maria

January 16, 2020
January 16, 2020
January 16, 2020
January 16, 2020

19
22
22
25

12
17
24
21

22
22
25
26

3
22
16
5

Kertesz, Maria

January 16, 2020

26

7

30

9

Kertesz, Maria

January 16, 2020

30

18

31

21

Kertesz, Maria

January 16, 2020

32

8

40

23

AngioDynamics' Objections to Affirmative
Designations
Asks for lay opinion, foundation, designations
incomplete to describe "the deal you were
describing"
403/Cumulative (Morpheus), see Obj. to Ex. D411 at ECF #411
403/Cumulative (Morpheus), see Obj. to Ex. D048 above
403/Cumulative (Morpheus), see Obj. to Ex. D048 above
403/Cumulative (Morpheus), see Obj. to Ex. D048 above
403/Cumulative (Morpheus), see Obj. to Ex. D048 above
403/Cumulative (Morpheus), see Obj. to Ex. D048 above
18:18-20:16 403: the questions are not specific
to time whether the PICC was used in an IR
suite or bedside; whether a TLS was used;
malpositions are due to placement not a feature
of the PICC; doesn't say whether placed with
TLS or not; 19:10 vague, 403 re frequency
19:12-19:22 403: the questions are not specific
to time, whether the PICC was used in an IR
suite or bedside; whether a TLS was used;
malpositions are due to placement not a feature
of the PICC

AngioDynamics'
Counter-Designations

Court’s Ruling
Overruled
Overruled
Overruled
Overruled
Sustained as to 217:12 to
217:14
Sustained
Sustained

50:1-54:25

Overruled

50:1-54:25

Overruled

76:20-77:21; 78:20-23;
77:9-19; 78:6-7; 78:17-15
50:1-54:25; 76:20-77:21;
78:20-23; 77:9-19; 78:6-7;
78:17-15
50:1-54:25; 76:20-77:21;
78:20-23; 77:9-19; 78:6-7;
78:17-15

Case No. 1:17-cv-598 (BKS)(CFH)
Date:_________ Presiding Judge: Honorable Brenda K. Sannes

Name of Deponent

Date of Testimony

United States District Court
For the Northern District of New York

Affirmative Page Affirmative Line
From
From

Affirmative
Page To

Affirmative
Line To

AngioDynamics' Objections to Affirmative
Designations

Kertesz, Maria

January 16, 2020

41

1

43

14

Kertesz, Maria

January 16, 2020

44

3

44

5

Kertesz, Maria

January 16, 2020

45

18

46

6

Kertesz, Maria

January 16, 2020

46

17

47

2

Kertesz, Maria

January 16, 2020

76

18

76

23

Kertesz, Maria

January 16, 2020

77

7

77

8

Kertesz, Maria

January 16, 2020

84

5

84

18

Kertesz, Maria

January 16, 2020

85

13

86

11

Kertesz, Maria
Sands, Mark
Sands, Mark
Sands, Mark
Sands, Mark
Sands, Mark
Sands, Mark
Sands, Mark
Sands, Mark
Sands, Mark
Sands, Mark
Sands, Mark
Sands, Mark
Sands, Mark
Sands, Mark
Sands, Mark

January 16, 2020
December 9, 2019
December 9, 2019
December 9, 2019
December 9, 2019
December 9, 2019
December 9, 2019
December 9, 2019
December 9, 2019
December 9, 2019
December 9, 2019
December 9, 2019
December 9, 2019
December 9, 2019
December 9, 2019
December 9, 2019

86
6
7
10
14
15
17
22
22
34
35
35
40
40
46
48

17
25
19
23
4
10
7
6
12
23
5
17
10
17
17
22

87
7
10
11
15
15
18
22
23
34
35
38
40
41
46
49

19
2
12
11
7
18 Document not on exhibit list ECF #411
10
8
5
25
5
4
13 Incomplete question; foundation
3 Incomplete question; foundation
21
20

Dated: September 25, 2022

AngioDynamics'
Court’s Ruling
Counter-Designations
50:1-54;25; 76:20-77:21;
78:20-23; 77:9-19; 78:6-7;
78:17-15
50:1-54:25; 76:20-77:21;
78:20-23; 77:9-19; 78:6-7;
78:17-15
46:7-9; 76:20-77:21;
78:20-23; 77:9-19; 78:6-7;
78:17-15
76:20-77:21; 78:20-23;
77:9-19; 78:6-7; 78:17-15
76:20-77:21; 78:20-23;
77:9-19; 78:6-7; 78:17-15
76:20-77:21; 78:20-23;
77:9-19; 78:6-7; 78:17-15
76:20-77:21; 78:20-23;
77:9-19; 78:6-7; 78:17-15
76:20-77:21; 78:20-23;
77:9-19; 78:6-7; 78:17-15
76:20-77:21; 78:20-23;
77:9-19; 78:6-7; 78:17-15

Sustained
20:23-22:5

41:22-24; 42:3-5
41:22-24; 42:3-5
46:22-47:5
40:21-24; 50:24-51:3

Overruled
Overruled